Target Price | $72.00 |
Price | $67.87 |
Potential | 6.09% |
Number of Estimates | 24 |
24 Analysts have issued a price target Mondelez International 2026 . The average Mondelez International target price is $72.00. This is 6.09% higher than the current stock price. The highest price target is $79.00 16.40% , the lowest is $63.00 7.18% . | |
A rating was issued by 29 analysts: 20 Analysts recommend Mondelez International to buy, 9 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Mondelez International stock has an average upside potential 2026 of 6.09% . Most analysts recommend the Mondelez International stock at Purchase. |
21 Analysts have issued a sales forecast Mondelez International 2025 . The average Mondelez International sales estimate is $38.3b . This is 4.90% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $38.7b 6.01% , the lowest is $37.4b 2.54% .
This results in the following potential growth metrics:
2024 | $36.4b | 1.18% |
---|---|---|
2025 | $38.3b | 4.97% |
2026 | $39.9b | 4.20% |
2027 | $41.3b | 3.70% |
2028 | $42.8b | 3.64% |
2029 | $45.0b | 5.10% |
18 Analysts have issued an Mondelez International EBITDA forecast 2025. The average Mondelez International EBITDA estimate is $6.7b . This is 10.84% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $6.9b 15.02% , the lowest is $6.2b 2.41% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $6.6b | 3.55% |
---|---|---|
2025 | $6.7b | 0.44% |
2026 | $7.2b | 7.65% |
2027 | $7.6b | 6.48% |
2028 | $7.6b | 0.08% |
2029 | $8.6b | 13.03% |
2024 | 18.20% | 4.67% |
---|---|---|
2025 | 17.42% | 4.28% |
2026 | 17.99% | 3.27% |
2027 | 18.47% | 2.67% |
2028 | 17.84% | 3.41% |
2029 | 19.19% | 7.57% |
6 Mondelez International Analysts have issued a net profit forecast 2025. The average Mondelez International net profit estimate is $3.5b . This is 0.31% lower than the net profit for the last 12 months(TTM). The highest net profit forecast is $3.8b 8.55% , the lowest is $3.3b 6.32% .
This results in the following potential growth metrics and future Net Margins:
2024 | $4.4b | 5.52% |
---|---|---|
2025 | $3.5b | 21.59% |
2026 | $4.4b | 25.31% |
2027 | $4.8b | 9.17% |
2028 | $5.1b | 7.28% |
2029 | $5.5b | 7.19% |
2024 | 12.15% | 6.63% |
---|---|---|
2025 | 9.08% | 25.28% |
2026 | 10.92% | 20.26% |
2027 | 11.49% | 5.22% |
2028 | 11.90% | 3.57% |
2029 | 12.13% | 1.93% |
6 Analysts have issued a Mondelez International forecast for earnings per share. The average Mondelez International EPS is $2.68 . This is 0.37% lower than earnings per share in the financial year 2024. The highest EPS forecast is $2.92 8.55% , the lowest is $2.52 6.32% .
This results in the following potential growth metrics and future valuations:
2024 | $3.42 | 5.52% |
---|---|---|
2025 | $2.68 | 21.64% |
2026 | $3.36 | 25.37% |
2027 | $3.67 | 9.23% |
2028 | $3.94 | 7.36% |
2029 | $4.22 | 7.11% |
Current | 25.22 | 29.27% |
---|---|---|
2025 | 25.31 | 0.36% |
2026 | 20.20 | 20.19% |
2027 | 18.50 | 8.42% |
2028 | 17.25 | 6.76% |
2029 | 16.09 | 6.72% |
Based on analysts' sales estimates for 2025, the Mondelez International stock is valued at an EV/Sales of 2.78 and an P/S ratio of 2.30 .
This results in the following potential growth metrics and future valuations:
Current | 2.92 | 7.30% |
---|---|---|
2025 | 2.78 | 4.65% |
2026 | 2.67 | 4.03% |
2027 | 2.58 | 3.57% |
2028 | 2.49 | 3.52% |
2029 | 2.37 | 4.85% |
Current | 2.41 | 8.65% |
---|---|---|
2025 | 2.30 | 4.67% |
2026 | 2.21 | 4.03% |
2027 | 2.13 | 3.57% |
2028 | 2.05 | 3.52% |
2029 | 1.95 | 4.85% |
Mondelez International...
Analyst | Rating | Action | Date |
---|---|---|---|
Barclays |
Overweight
➜
Overweight
|
Unchanged | May 01 2025 |
Morgan Stanley |
Overweight
➜
Overweight
|
Unchanged | Apr 30 2025 |
Stifel |
Buy
➜
Buy
|
Unchanged | Apr 30 2025 |
RBC Capital |
Outperform
➜
Outperform
|
Unchanged | Apr 30 2025 |
RBC Capital |
Outperform
➜
Outperform
|
Unchanged | Apr 28 2025 |
DA Davidson |
Buy
➜
Neutral
|
Downgrade | Apr 24 2025 |
Evercore ISI Group |
Outperform
➜
Outperform
|
Unchanged | Apr 23 2025 |
Analyst Rating | Date |
---|---|
Unchanged
Barclays:
Overweight
➜
Overweight
|
May 01 2025 |
Unchanged
Morgan Stanley:
Overweight
➜
Overweight
|
Apr 30 2025 |
Unchanged
Stifel:
Buy
➜
Buy
|
Apr 30 2025 |
Unchanged
RBC Capital:
Outperform
➜
Outperform
|
Apr 30 2025 |
Unchanged
RBC Capital:
Outperform
➜
Outperform
|
Apr 28 2025 |
Downgrade
DA Davidson:
Buy
➜
Neutral
|
Apr 24 2025 |
Unchanged
Evercore ISI Group:
Outperform
➜
Outperform
|
Apr 23 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.